Breakthrough test could spot kidney patients headed for failure
NCT ID NCT02199145
Summary
This study tested whether a specific blood test could better predict which patients with an autoimmune kidney disease called membranous nephropathy are at highest risk for their kidneys getting worse. Researchers followed 52 patients to see if measuring certain antibodies using a test involving mouse proteins could identify those likely to progress to severe kidney damage or failure. The goal is to confirm if this test can reliably spot high-risk patients early, so doctors can monitor them more closely or consider stronger treatments sooner.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEMBRANOUS NEPHROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AP-HM
Marseille, 13354, France
-
CHU de Besançon
Besançon, France
-
Nephrology Department, Nice University Hospital
Nice, 06003, France
Conditions
Explore the condition pages connected to this study.